Overview

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Status:
RECRUITING
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atrophy (MSA)
Phase:
PHASE2
Details
Lead Sponsor:
Tiziana Life Sciences LTD